Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome
- 1 December 1984
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 87 (6), 1228-1232
- https://doi.org/10.1016/0016-5085(84)90187-2
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Urinary Excretion of Thromboxane B 2 in Patients with Venous Thromboembolic DiseaseChest, 1984
- Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular DiseaseNew England Journal of Medicine, 1984
- Regulation of urinary thromboxane B2 in man: Influence of urinary flow rate and tubular transportProstaglandins, 1984
- Selective inhibition of thromboxane synthesis with dazoxiben in animals and manThrombosis Research, 1983
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells.JCI Insight, 1983
- STIMULATION OF ARACHIDONIC ACID METABOLISM AND GENERATION OF THROMBOXANE A2 BY LEUKOTRIENES B4, C4 AND D4 IN GUINEA‐PIG LUNG in vitroBritish Journal of Pharmacology, 1982
- THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGYThe Lancet, 1981
- Thromboxane A2in Vasotonic Angina PectorisNew England Journal of Medicine, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981